Botanical species · safety record

Phyllanthus emblica

The EFSA Compendium of Botanicals holds 18 constituent measurements and 2 adverse-effect records for Phyllanthus emblica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Phyllanthus emblica L.

18Constituent measurements

2Safety records

6Cited sources

728Licensed products (Canada)

Also recorded as

Emblica officinalis Gaertn.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 728 licensed products naming Phyllanthus emblica as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA
Fresh
fluid

Source material stated

Aged bark
Amla fruit extract
Berry/Berries
Fruit
Fruit (standardized extract)
Fruit extract
Fruit flesh
Fruit pericarp

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Fruit unspecified	Solvent extraction	—	Phytochemical screening	Resolve DOI
Chebulagic acid	Fruit unspecified	Solvent extraction	—	—	Resolve DOI
Corilagin	Fruit unspecified	Solvent extraction	—	—	Resolve DOI
Coumarins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	Resolve DOI
Ellagitannins (hydrolysable tannins)	Fruit unspecified	Solvent extraction	—	—	Resolve DOI
Ellagitannins (hydrolysable tannins)	Fruit unspecified	Solvent extraction	—	LC-MS	Resolve DOI
Gallic acid	Fruit unspecified	Solvent extraction	—	—	Resolve DOI
Glucosinolates	Seed	Solvent extraction	≤ 56.598 Millimole/kilogram	HPLC-UV	Resolve DOI
Glucosinolates	Seed	Solvent extraction	≥ 59.918 Millimole/kilogram	HPLC-UV	Resolve DOI
Saponins	Fruit unspecified	Solvent extraction	—	Phytochemical screening	Resolve DOI
Sinigrin	Seed	Solvent extraction	≤ 35.927 Millimole/kilogram	HPLC-UV	Resolve DOI
Sinigrin	Seed	Solvent extraction	≥ 36.147 Millimole/kilogram	HPLC-UV	Resolve DOI
Beta-glucogallin	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Beta-glucogallin	Stem / stalk	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Ellagitannins (hydrolysable tannins)	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Ellagitannins (hydrolysable tannins)	Stem / stalk	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Gallic acid	Fruit unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Piperine	Fruit unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Fruit unspecified	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI
Digestive	Digestive	Fruit unspecified	Solvent extraction	House mouse (as animal)	Acute toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Mehmood, Malik Hassan., Rehman, Abdul., Rehman, Najeeb-ur., Gilani, Anwarul-Hassan. Studies on Prokinetic, Laxative and Spasmodic Activities of Phyllanthus emblica in Experimental Animals . Phytotherapy research, 2013, vol. 27, no. 7, p. 1054-1060. DOI
Avula, Bharathi., Wang, Yan-Hong., Wang, Mei., Shen, Yun-Heng., Khan, Ikhlas A. Simultaneous Determination and Characterization of Tannins and Triterpene Saponins from the Fruits of Various Species of Terminalia and Phyllantus emblica Using a UHPLC-UV-MS Method: Application to Triphala. PLANTA MEDICA, 2013, vol. 79, no. 2, p. 181-188. DOI
Hu, Ye., Liang, Hao., Yuan, Qipeng., Hong, Yuancheng. Determination of glucosinolates in 19 Chinese medicinal plants with spectrophotometry and high-pressure liquid chromatography . Natural product research, 2010, vol. 24, no. 13, p. 1195-1205. DOI
Yang, Baoru., Kortesniemi, Maaria., Liu, Pengzhan., Karonen, Maarit., Salminen, Juha-Pekka. Analysis of Hydrolyzable Tannins and Other Phenolic Compounds in Emblic Leafflower (Phyllanthus emblica L.) Fruits by High Performance Liquid Chromatography-Electrospray Ionization Mass Spectrometry . Journal of agricultural and food chemistry, 2012, vol. 60, no. 35, p. 8672-8683. DOI
Patil, Smita G., Jadhav, Varsha M., Kadam, Vilasrao J. Method development and validation for simultaneous estimation of gallic acid and piperine in herbal extract and polyherbal formulation by HPTLC. World journal of pharmacy and pharmaceutical sciences, 2015, vol. 4, no. 1, p. 738-748.
Srivastava, Satendra K., Ranjan, Shri. Physiological studies on plant tannis. II. Variation of tannin compounds in the leaves and twigs of Emblica officinalis during fruiting season. Flora (jena), abteilung a: physiologie und biochemie, 1966, vol. 157, no. 3, p. 201-10.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature